Aguilera POR, González VD, Gómez ÁF

Language: Spanish
References: 12
Page: 88-92
PDF size: 143.25 Kb.

ABSTRACT

Neurocysticercosis is an infection of the central nervous system caused by the accidental ingestion of eggs of Taenia Solium, constituting the most frequent parasitosis of the system itself. It is a common problem in many Latin American, Asian and African countries; in endemic areas, it is considered the main etiology of late-onset epilepsies. The case of a 39-year-old male patient with a history of behavioral disorders and several seizures for a year is presented. For this reason he was transferred to the Main Military Hospital of Luanda and admitted to the Psychiatry Service with a presumptive diagnosis of hysterical neurosis. A month after his discharge, he was referred again this time to the Neurology Service of the hospital itself. A physical examination was performed, supplementary tests were indicated, and a chest X-ray and tomography were performed, which showed images suggestive of active neurocysticercosis. Pharmacological treatment and physiotherapy were indicated. After eighty days, the patient was discharged, conscious, oriented, and asymptomatic. The objective of the presentation is to draw the attention of specialists who collaborate in different parts of the world as it is an extremely rare disease in Cuba and which they must face with certain frequency in other latitudes.

REFERENCES

1. García HH, González AE, Rodríguez S, Gonsalves G, Llanos F, Tsang V, et al. Epidemiología y control de la cisticercosis en el Perú. Rev Perú Med Exp Salud Pública[Internet]. 2010[citado 12 Nov 2019];27(4):[aprox. 5p.]. Disponible en: https://www.researchgate.net/publication/262428305_Epidemiologia_y_control_de_la_cisticercosis_en_el_Peru.

2. Serrano G, Ortiz JC, Ochoa I. Neurocisticercosis. Presentación de un caso. Medisur[Internet]. 2009[citado 16 Sep 2019]:7(2):[aprox. 10p.]. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812015000300023.

3. García HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13(12):1202-15. 4 García HH. Neurocysticercosis. Neurol Clin. 2018;36(4):851-64.

4. García HH. Neurocysticercosis. Neurol Clin. 2018;36(4):851-64.

5. Gripper LB, Welburn SC. Neurocysticercosis infection and disease. A review. Acta Trop. 2017; 166(1):218-24.

6. White AC, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, et al. Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2018;66(8):e49-e75.

7. O'Neal SE, Flecker RH. Hospitalization Frequency and Charges for Neurocysticercosis, United States, 2003-2012. Emerg Infect Dis. 2015;21(6):969-76.

8. García HH, del Brutto OH. Antiparasitic treatment of neurocysticercosis - the effect of cyst destruction in seizure evolution. Epilepsy Behav. 2017;76(1):158-62.

9. Raibakgar P, Berkowitz AL. The many faces of neurocysticercosis. J Neurol Sci. 2018;390(1):75-6.

10. Sarría S, Frascheri L, Siurana S, Auger C, Rovira A. Neurocisticercosis. Hallazgos radiológicos. Radiología. 2013;55(2):130-41.

11. Thapa K, Romo ML, Carpio A, Leslie D, Andrews H, Hauser WA, et al. The effect of albendazole treatment on non-seizure outcomes in patients with symptomatic neurocysticercosis. Trans R Soc Trop Med Hyg. 2018;112(2):73-80.

12. Samannodi MS, Zhao A, Hasbun R. Use of Ivermectin in Neurocysticercosis: A case report. Am J Case Rep. 2018;19(1):1378-81.